| |
| Trade Name | LT-CAGE PEEK LUMBAR TAPERED FUSION DEVICE |
| Classification Name | intervertebral fusion device with bone graft, lumbar |
| Generic Name | intervertebral body fusion device |
| Regulation Number | 888.3080 |
| Applicant | MEDTRONIC SOFAMOR DANEK USA, INC. |
| PMA Number | P970015 |
| Supplement Number | S022 |
| Date Received | 10/30/2002 |
| Decision Date | 09/10/2003 |
| Product Code | |
| Advisory Committee |
Orthopedic |
| Supplement Type | normal 180 day track |
| Supplement Reason | change design/components/specifications - material |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval for the lt-cage peek lumber tapered fusion device, which is manufactured from polyetheretherke-tone, with the trade name of peek-optima lt1. The device, as modified, will be marketed under the trade name lt-cage peek lumbar tapered fusion device and is indicated for spinal fusion procedures in skeletally mature patients with degernerative disc disease (ddd) at one level from l2-s1. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These ddd patients also have up to grade i spondylolisthesis or retrolisthesis at the involved level. Lt-cage peek implants are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach. Patients receiving the lt-cage peek lumbar tapered fusion device should have at least six months of non-operative treatment prior treatment with the lt-cage peek device. |